T. Shipley

Design and x-ray crystal structures of high-potency nonsteroidal glucocorticoid agonists exploiting a novel binding site on the receptor

I. McLay, Shawn P. Williams, I. Uings, 2009, Proceedings of the National Academy of Sciences.

Addressing species specific metabolism and solubility issues in a quinoline series of oral PDE4 inhibitors.

B. Judkins, T. Shipley, A. Craven, 2010, Bioorganic & medicinal chemistry letters.

Quinolines as a novel structural class of potent and selective PDE4 inhibitors: optimisation for oral administration.

M. Lindvall, D. Somers, T. Shipley, 2009, Bioorganic & medicinal chemistry letters.

Aryl aminopyrazole benzamides as oral non-steroidal selective glucocorticoid receptor agonists.

H. T. Jones, James M. Woolven, I. McLay, 2009, Bioorganic & medicinal chemistry letters.

Cell Penetrant Inhibitors of the KDM4 and KDM5 Families of Histone Lysine Demethylases. 2. Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives.

David M. Wilson, Melanie V. Leveridge, G. Drewes, 2016, Journal of medicinal chemistry.

Efficient synthesis of an α-trifluoromethyl-α-tosyloxymethyl epoxide enabling stepwise double functionalisation to afford CF3-substituted tertiary alcohols

H. T. Jones, G. Hardy, D. Coe, 2008 .

Optimisation of a novel series of potent and orally bioavailable azanaphthyridine SYK inhibitors.

David M. Wilson, J. Liddle, D. Lugo, 2016, Bioorganic & medicinal chemistry letters.